Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency
Éric Bouffet(Hospital for Sick Children), Uri Tabori(Universität Hamburg), Brittany Campbell(Hospital for Sick Children), Gary Mason, Roula Farah, Jordan R. Hansford, Michael F. Walsh(Memorial Sloan Kettering Cancer Center), Alyssa Reddy, Rachel Laframboise, Nancy Klauber‐DeMore(MUSC Hollings Cancer Center), Lindsay L. Peterson(Washington University in St. Louis), Vijay Ramaswamy(Hospital for Sick Children), Ronit Elhasid, Rina Dvir, Adam Shlien(Hospital for Sick Children), Andrew Dodgshun, Peter B. Dirks(Hospital for Sick Children), Nataliya Zhukova, Joerg Krueger(Hospital for Sick Children), Cynthia Hawkins(Hospital for Sick Children), Michael Sullivan, Nada Jabado(McGill University), Richard de Borja, Gideon Rechavi(Tel Aviv University), Daniele Merico(Hospital for Sick Children), Shlomi Constantini(Tel Aviv University), Roy Dudley(McGill University Health Centre), Carol Durno, Melyssa Aronson, Valérie Larouche, Vanja Cabric(Memorial Sloan Kettering Cancer Center), Jeffrey Atkinson, David Malkin(University of Toronto), Michael D. Taylor(Hospital for Sick Children), Steffen Albrecht(Montreal Children's Hospital), Sunil J. Patel, Zane Cohen(Sinai Health System), Samina Afzal, Michal Yalon(Sheba Medical Center), Michael Osborn, Vanan Magimairajan, Scott Lindhorst
Cited by 867
Related Papers
The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure.
|PubMed|1985|2.1k
Clinical and biological implications of driver mutations in myelodysplastic syndromes
|Blood|2013|1.8k
The Life History of 21 Breast Cancers
|Cell|2012|1.5k
Medulloblastoma Comprises Four Distinct Molecular Variants
|Journal of Clinical Oncology|2010|1.4k